Migraine Drug Pipeline Report Now Available
Posted on: Thursday, 13 September 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68278) has announced the addition of "Central Nervous System - Migraine Drug Pipeline Report" to their offering.
"Central Nervous System - Migraine Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of migraine drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Contents:
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Migraine Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Migraine Projects
--Top 20 companies in early stage Migraine Projects
Full Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68278.
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Huaneng Power International, Inc. Obtains Approval on the Second Unit of Huaneng Jinggangshan Power Plant Phase II Project
- ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
- Lockheed Martin SBIRS Team Advancing to Follow-on Production Phase
- ONEOK Partners Announces Completion of Guardian Pipeline Expansion and Extension Project
- 'Project Egypt: A Politically Incorrect View': An American Contractor Offers Uncensored Take on Egyptian Project and Society
- Victhom announces the completion of the second phase of the apnea therapy development
- Silver Dragon Completes Phase 1 of Its Exploration and Development Program for the Erbahuo Silver Mine
- ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
- LAWA Appoints David Shuter As the New Deputy Executive Director of Project and Facilities Development Services
- Project Aims to Develop Hydrogen Power
 |
 |
User Comments (0)
RSS Feeds